<DOC>
	<DOCNO>NCT02806349</DOCNO>
	<brief_summary>The purpose study determine whether co-administration konjac-glucomannan fibre blend American ginseng randomize , placebo-controlled , cross-over trial improve diabetes management .</brief_summary>
	<brief_title>Konjac-Glucomannan Fibre Blend American Ginseng Type 2 Diabetes</brief_title>
	<detailed_description>The study use partially blind , randomize , placebo control , crossover design . Due nature fibres possible blind participant respect type fibre . The study divide two phase phase four 4-week run-in period , 12-week treatment period , separate minimum 4-week wash-out period . The treatment consist ad libitum Canadian Diabetes Association recommend diet supplemented capsule contain either cornstarch ( control ) AG ( test ) fiber supplement consist either wheat bran ( control ) viscous fiber blend konjac mannan xanthan ( test ) . Participants ask attend clinic week -4 , 0 , 3 , 6 , 12 phase . Outcome measure There three level outcome measure include efficacy , safety , compliance . Statistical analysis The result present mean ± SEM consider statistically significant p &lt; 0.05 . Statistical analysis perform use SAS version 8.2 ( SAS Institute , Cary , NC ) . Parametric analysis conduct follow comparison sample distribution normal distribution ( Shapiro-Wilk Kolmogorov-Smirnov test ) . GLM use perform two-way ANOVA detect difference outcome variable treatment visit , control treatment sequence sex . If effect treatment significant percent difference calculate week 12 test control analyze use GLM repeat measure one-way ANOVA control sex . Parametric analyse conduct follow comparison sample distribution normal distribution ( Shapiro-Wilk Kolmogorov-Smirnov test ) . The test reject null hypothesis α=0.05 . All comparison pair , thus participant serve his/her control . As cross-over study , participant complete study include analysis .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>( 1-6 ) -alpha-glucomannan</mesh_term>
	<criteria>Diagnosis type 2 diabetes least 1 year age 40 75 year old treat diet anti hyperglycemic medication HbA1c 6.5 % 8.4 % Systolic blood pressure &lt; 140mmHg Diastolic blood pressure &lt; 90mmHg Clinically euthyroid Normal renal liver function treat insulin age le 40 old 75 year old start trial</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>American ginseng</keyword>
	<keyword>Konjac glucomannan fiber</keyword>
</DOC>